Linkedin-in Facebook-f
Our Portfolio Companies
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
Briefcase Loading...

Check all that apply

Portfolio Category: Medical Devices-Digital Health

Cultivo

Edible Biosymbiotic ex-vivo Cultures
Medical Devices-Digital Health

Cultivo

Edible Biosymbiotic ex-vivo Cultures

Established in 2023 by

Prof. Ofra Benny

BD Contact

Ariela Markel

Summary

Medical Devices-Digital Health
Linkedin-in

ReadERx

Finding new solutions with small molecules against cancer.
Diagnostics, Medical Devices-Digital Health, Pharmaceuticals

ReadERx

Finding new solutions with small molecules against cancer.

Established in 2023 by

Prof. Joel Yisraeli

BD Contact

Ariela Markel

Summary

DiagnosticsMedical Devices-Digital HealthPharmaceuticals
Linkedin-in

BeWeld Medical

Manufacturer of medical grafts
Medical Devices-Digital Health

BeWeld Medical

Manufacturer of medical grafts

Established in 2022 by

Prof. Daniel Cohn

BD Contact

Ariela Markel

Summary

BeWeld developing revolutionary tech which enable Manufacturer of medical grafts to machined and automated their MFG

Medical Devices-Digital Health

https://www.medxelerator.com/

Linkedin-in

Bio Pass Pharma

Nasal Administration of Drugs
Medical Devices-Digital Health, Pharmaceuticals

Bio Pass Pharma

Nasal Administration of Drugs

Established in 2022 by

Prof. Elka Touitou

BD Contact

Ariela Markel

Summary

Compositions and methods for nasal administration of drugs to brain and for systemic effect

Medical Devices-Digital HealthPharmaceuticals
Linkedin-in

MyOR

Skin as a predictive platform
Diagnostics, Medical Devices-Digital Health

MyOR

Skin as a predictive platform

Established in 2018 by

Prof. Ron Kohen

BD Contact

Ariela Markel

Summary

MyOR prevents a range of health issues using innovative, holistic solutions that combine predictive, noninvasive, monitoring technologies and customized products to help the body help itself. Our monitoring technologies leverage skin-sensing techniques and data science tools to gain new insight into systemic health and reveal the inner workings of your body. With these technologies in hand, MyOR customizes care solutions to prevent health conditions from developing.

 

DiagnosticsMedical Devices-Digital Health

https://www.myorcare.com/

Linkedin-in

LipoMedix

Focused on the development of an innovative, safe and effective cancer therapy based on liposome delivery
Diagnostics, Medical Devices-Digital Health, Pharmaceuticals

LipoMedix

Focused on the development of an innovative, safe and effective cancer therapy based on liposome delivery

Established in 2011 by

Alberto A Gabizon

BD Contact

Ariela Markel

Summary

LipoMedix is a development-stage privately held company focused on the development of an innovative, safe and effective cancer therapy based on liposome delivery. The Company was established in order to advance the pharmaceutical and clinical development of a patented new chemical entity prodrug of mitomycin-C and its efficient delivery in liposomes to cancer-affected target organs. This formulation known as Promitil  – Pegylated Liposomal Mitomycin-C Prodrug (PL-MLP) – overcomes the problems associated with mitomycin-C toxicity and turn it into a state-of-the-art anti-cancer drug that will potentially become the therapy of choice in a variety of cancers, especially those derived from the gastrointestinal tract (stomach, pancreas, colorectal). The inventor and scientific founder, of LipoMedix is Prof. Alberto Gabizon of the Hebrew University – Shaare Zedek Medical Center who is also the co-inventor and co-developer of Doxil, (the first FDA-approved nano-drug in cancer therapy). As co-developer of Doxil® Prof. Gabizon is one of the few scientists intimately familiar with the successful development & commercialization process of liposomal drugs.

DiagnosticsMedical Devices-Digital HealthPharmaceuticals

http://www.lipomedix.com/

Linkedin-in

Voyager Medical Research

Wound-closure and Biocompatible Polymers
Medical Devices-Digital Health

Voyager Medical Research

Wound-closure and Biocompatible Polymers

Established in 2015 by

Prof. Daniel Cohn

BD Contact

Ariela Markel

Summary

Everything we do is intended to reduce post-surgical complications and help save lives. We do so by developing unique, proprietary polymers that are designed specifically to help prevent complications. Our first product, Voyager Medical Suture, addresses the post-surgical complication of Incisional Hernia, that is effecting up to 20% of every patient undergoing a Laparotomy, leading to 3.4% mortality. Our team is highly experienced and recognized in the field of wound-closure and biocompatible polymers.

 

 

Medical Devices-Digital Health

https://www.voyager-suture.com/

Linkedin-in

Tissue Dynamics

Animal Free Artificial Intelligence
Diagnostics, Medical Devices-Digital Health, Pharmaceuticals

Tissue Dynamics

Animal Free Artificial Intelligence

Established in 2017 by

Prof. Yaakov Nahmias

BD Contact

Ariela Markel

Summary

Tissue Dynamics bionic microtissues are three dimensional human organoids embedded with electro optical sensors that provide critical insight into human-relevant mechanisms. These proprietary physiological models are powered by unprecedented AI & automation capabilities. 

DiagnosticsMedical Devices-Digital HealthPharmaceuticals

https://www.tissuedynamics.com/

Linkedin-in

Swift Duct

Medical Equipment Manufacturing
Diagnostics, Medical Devices-Digital Health

Swift Duct

Medical Equipment Manufacturing

Established in 2020 by

Prof. Yaakov Nahmias

BD Contact

Ariela Markel

Summary

Developer of a medical navigational tool designed to reduce the length of ERCP procedure. The company’s tool helps in preventing inflammation that can be caused during the procedure if the catheter is accidentally inserted into the pancreas duct, rather than the gallbladder duct, enabling surgeons to accurately diagnose and treat patients suffering from bile duct blockage.

DiagnosticsMedical Devices-Digital Health
Linkedin-in

Splisense

Developing novel therapies for genetic diseases by inhalation, currently focusing on splicing mutations in the CFTR gene for treating Cystic Fibrosis (CF) patients
Diagnostics, Medical Devices-Digital Health, Pharmaceuticals

Splisense

Developing novel therapies for genetic diseases by inhalation, currently focusing on splicing mutations in the CFTR gene for treating Cystic Fibrosis (CF) patients

Established in 2016 by

Prof. Batsheva Kerem

BD Contact

Ariela Markel

Summary

SpliSense is an Israel-based company focused on transformative RNA-based treatments. Our pioneering platform harnesses Antisense Oligonucleotides (ASOs) for treatment of genetic diseases such as Cystic Fibrosis and pulmonary diseases. Our innovative approach targets unmet needs in pulmonary diseases. SpliSense aims to target the root cause of the disease, to overcome specific genetic mutations and restore protein function.

DiagnosticsMedical Devices-Digital HealthPharmaceuticals

https://splisense.com/

Linkedin-in
ADDRESS

Hi-Tech Park, Edmond J. Safra
Campus, Bungalow 2.6
Givat-Ram, Jerusalem
P.O. Box 39135
91390 Israel

CONTACT US
  • Phone: +972-2-658-6688
  • Fax: +972-2-658-6689
  • Email: [email protected]
FOLLOW US
Twitter Linkedin-in Facebook-f Youtube
COPYRIGHT
Twitter Linkedin-in Facebook-f Youtube
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
Search Our Technologies
Find a Research Expert
Our Portfolio Companies
Briefcase Loading...